Updates From Four Diversified Stocks – OVN, CDA, IDZ, OCL

Updates From Four Diversified Stocks - OVN, CDA, IDZ, OCL

Four stocks trading on ASX – Oventus Medical Limited, Codan Limited, Indoor Skydive Australia Group Limited and Objective Corporation Limited – started their trading session on 15 July 2019 with positive market updates. Let us have a broader look at these four stocks.

Oventus Medical Limited

Oventus Medical Limited (ASX: OVN) is an Australia registered company, which is involved in the development of medical devices, targeting people with snoring and obstructive sleep apnoea (OSA). The company was officially listed on ASX in July 2016.

New Agreement: On 15 July 2019, the company via a release updated the market regarding an agreement with an American sleep medicine group. Under the terms of the agreement, which is OVN’s first material contract in the United States, the latter will adopt the former’s O2Vent® treatment platform for the treatment of OSA across eight clinical treatment sites in the US states of Texas, Arizona and New Mexico. Each site will receive a minimum monthly quota of 20 O2Vent® devices.

The company further stated that this contract recognises OVN as the primary supplier of oral appliances for the OSA treatment. The company expects to officially launch the agreement as soon as the U.S. Food & Drug Administration would give a regulatory clearance to O2Vent® Optima oral device.

What is OSA?

Obstructive sleep apnoea is a medical illness, wherein the patients experience an absence of breathing that occurs during sleep and leads to disruptive sleep that compromises daytime functions, resulting in excessive sleepiness, memory impairment, depression and a host of comorbidities. This happens when there is an obstruction or collapse of the nose, soft palate and lateral walls of the airway.

The Rollout of O2Vent® Optima: Optima, which is easier to manufacture and carry a low cost of goods, is a new lightweight, nylon version of the company’s O2Vent® oral device. The company launched O2Vent® Optima in January 2019 in Australia and in February 2019 in Canada.

Further Agreements: Oventus Medical Limited is anticipating securing more agreements across the North American region over the coming 12-24 months. It further stated that the negotiations are on track with multiple groups throughout the US, Australia and Canada with a view to significant scaling by the end of 2019 and 2020.

According to the company, the current device market for the treatment of obstructive sleep apnoea stands at US$ 4.4 billion. Of the total, 10% are oral appliances, whose market is projected to grow at a CAGR of 25%.

Stock Performance: On 15 July 2019, the stock of OVN last traded at a price of $ 0.310 per share, up 5.085% from its previous closing price. The company has a market capitalisation of $ 31.25 million and 105.94 million outstanding shares. The stock has produced returns of 37.21%, 28.26% and -3.28% for the one month, three months and six months period, respectively.

Codan Limited

Codan Limited (ASX: CDA) is engaged in the manufacturing, designing and marketing of several high value-added electronics products for the global environment business. The company was officially listed on ASX in November 2003.

New Contract: On 15 July 2019, the company announced that its division Codan Communications secured a contract for supplying a tactical communications network to an East African government department. The contract worth A$ 15 million entails a full communications platform, incorporating Codan radios and interoperability solution along with a suite of third-party products. The network is due for delivery in 1H FY20.

Codan Communications is involved in the design and production of premium communications solutions. Under the communications segment, the company has tactical and land mobile radio solutions. The segment reported sales amounting to $ 57 million in FY18. Tactical communications has an addressable market size of US$ 1.9 billion for man-portable, stationary and vehicular communications, while estimated addressable market size for land mobile radio markets is US$ 900 million.

1H FY19 Results: For 1H FY19, Codan registered sales and EBITDA of $ 128 million and $ 38 million, respectively. It reported a net profit after tax and EPS of $ 22 million and 12.4 cents for the period. The metal detection sales and segment profit witnessed a rise of 29% over the previous first half.  The communications sales were increased by 41% and segment profit increased by 85% over the same period a year ago. The company has a strong balance sheet with net cash of $ 13 million. In terms of dividend, the company paid an interim and a special dividend of 4.0 cents and 2.5 cents, fully franked, respectively.

Outlook: Codan Limited is expecting increased sales in the second half of the financial year 2019 and anticipating strong results in 2H FY19. The company provided guidance for full year underlying NPAT to be in the ambit of $ 42 million – $ 45 million. With respect to the base business of the company, it is anticipating producing NPAT in the vicinity of $ 25 million and $ 30 million.

Stock Performance: On 15 July 2019, the stock of CDA last traded at a price of $ 3.630 per share, up 1.397% from its previous closing price. It has a market capitalisation of $ 641.64 million and 179.23 million outstanding shares. The stock has produced returns of 9.82%, 12.93% and 20.30% for the one month, three months and six months period, respectively.

Indoor Skydive Australia Group Limited

 

Indoor Skydive Australia Group Limited (ASX: IDZ) is a New South Wales based company, which is the owner and operator of indoor skydiving facilities. The company was officially listed on ASX in January 2013.

Investor Presentation: On 15 July 2019, the company released an investor presentation, under which it unveiled its plans regarding a capital raising amounting to A$ 3.4 million in order to support its growth, diversification and repair strategy.

As per the terms of Entitlement Offer, the eligible shareholders can subscribe 2.5 new ordinary shares for every one share held on the record date of 18 July 2019, at an offer price of $ 0.01. The offer price of $ 0.01 per new share demonstrates a discount of 38% to the 30-day volume weighted average price to 12 July 2019. IDZ will be issuing a maximum of 341,741,285 shares. Moreover, the minimum subscription for the Entitlement Offer to proceed is $ 2 million.

The funding by entitlement offer will allow substantial investment in growth activities, specifically introducing new revenue generating businesses, which include Virtual Reality offerings. Moreover, the company would direct the proceeds towards the execution of a new web platform and digital marketing strategy. It will finance further reduction to interest-bearing debt and other liabilities, as well as enhanced marketing initiatives to fuel revenue.

 In terms of repair strategy, the company stated that, in conjunction with the sale of its Perth facility and the material reduction in an interest-bearing debt, IDZ is now focused on new business streams, increasing operational performance, paying down its remaining debt and reducing costs. When it comes to the strategy for growth, the company is planning to make an investment in growth activities of $ 900k as well as introducing new website and sport flyer initiatives. In addition, it is planning to implement a digital marketing strategy.

Change in Board and Management: On 15 July 2019, the company also updated regarding board and management restructuring. Mr Jon Brett and James Spenceley have stepped down from the board and transitioned into an advisory role to assist the company with future growth initiatives in order to enable a smaller and more cost-effective board and management team. Moreover, the company appointed Mr Steve Baxter as Non-Executive Chairman, effective immediately.

Stock Performance: On 15 July 2019, the stock of IDZ last traded at a price of $ 0.010 per share, down 37.5% from its previous closing price. It has a market capitalisation of $ 2.19 million and 136.7 million outstanding shares. The stock has produced returns of 6.67%, -20.00% and -67.35% for the one month, three months and six months period, respectively.

 

Objective Corporation Limited

 

Objective Corporation Limited (ASX: OCL), operating in the Australian information technology sector, specialises in enterprise content management. It deals into technologies including document management, record keeping and web content management. The company was officially listed on ASX in August 2000.

FY19 Trading Update: In an ASX announcement on 15 July 2019, the company provided a trading update for FY19 along with outlook for the financial year 2020. The revenue numbers were replaced in FY19 with higher margin software revenue, which is generating improved profitability for OCL. The licence revenue witnessed a rise of 11% in FY19.

The company, reinforcing the success of its ongoing transition to subscription revenue, registered strong growth in all subscription product lines, with ECMaaS, Connect, Keystone and Trapeze growing 23%, 27%, 21% and 20%, respectively. During the financial year 2019, the company injected $ 12.7 million in its research & development activities, which represents 20% of revenue.

It reported a net profit after tax of A$ 9.1 million in FY19 as compared to A$ 7.4 million in FY18, which reflects year-on-year growth of 23%. The company’s cash balance stood at $ 34.6 million in FY19, up 61% from the same period a year ago. Previously, the company reported financial results for 1H FY19, wherein it posted revenue of $ 29 million.

Outlook: The company will be continuing to utilise the strong cash flow produced by the business to invest in its current product portfolio during FY20. It will also introduce new products via acquisitions, where it is strategically aligned. In addition, it is anticipating all business units to drive profit by the close of FY20.

Stock Performance: On 15 July 2019, the stock of OCL last traded at a price of $ 3.060 per share, up 8.897% from its previous closing price. It has a market capitalisation of $ 260.99 million and 92.88 million outstanding shares. The stock has produced returns of -1.06% and 0.72% for the three months and six months period, respectively.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report